Charlotte Jones-Burton
Directeur/Bestuurslid bij BLUEBIRD BIO, INC.
Vermogen: 16 947 $ op 30-04-2024
Actieve functies van Charlotte Jones-Burton
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BLUEBIRD BIO, INC. | Directeur/Bestuurslid | 07-03-2022 | - |
| Independent Dir/Board Member | 07-03-2022 | - | |
| Women of Color in Pharma | Oprichter | - | - |
| President | - | - | |
2 Flo Ventures LLC
 2 Flo Ventures LLC Investment ManagersFinance 2Flo Ventures LLC (2Flo Ventures) is a venture capital firm founded in 2021. The firm is headquartered in Chicago, Illinois. | Private Equity Investor | 01-06-2024 | - |
Loopbaan van Charlotte Jones-Burton
Eerdere bekende functies van Charlotte Jones-Burton
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Corporate Officer/Principal | 24-01-2022 | 02-10-2023 |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Corporate Officer/Principal | - | - |
Otsuka Pharmaceuticals (U.K.) Ltd.
 Otsuka Pharmaceuticals (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceuticals (U.K.) Ltd. operates as an investment holding British company with interests in pharmaceutical preparations. The company is based in Slough, UK. The CEO of the company is Stewart Pearce. | Corporate Officer/Principal | - | - |
Opleiding van Charlotte Jones-Burton
| Washington University in St. Louis | Undergraduate Degree |
| University of Maryland School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Health Technology |
Otsuka Pharmaceuticals (U.K.) Ltd.
Otsuka Pharmaceuticals (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceuticals (U.K.) Ltd. operates as an investment holding British company with interests in pharmaceutical preparations. The company is based in Slough, UK. The CEO of the company is Stewart Pearce. | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
2 Flo Ventures LLC
2 Flo Ventures LLC Investment ManagersFinance 2Flo Ventures LLC (2Flo Ventures) is a venture capital firm founded in 2021. The firm is headquartered in Chicago, Illinois. | Finance |
| Women of Color in Pharma |
